Primer: Viyash Scientific (VIYASH IN) - Aug 2026
Viyash Scientific has successfully executed a significant business transformation, marked by a merger and rebranding from Sequent Scientific,...
88 Views
Viyash Scientific: Animal Health + Life Science, Targeting 1000Cr EBITDA
Viyash Scientific rebrands, acquires BioForLife Italia, boosts EBITDA margin and expands platform, FY27 to test synergy benefits and CDMO growth.
142 Views
The Beat Ideas: Sequent Scientific Merger - CDMO Optionality with Margin Upside
NCLT approves Sequent-Viyash merger, creating INR 8,000 Cr+ Life Sciences platform with 56:100 swap ratio and management upgrade.
516 Views
Solara Active Pharma: Carving Out Ibuprofen to Recapture Margin
Solara's Q1 FY27 net profit up 55% YoY to INR 16.3 crore, debt reduced, considering sale of loss-making Ibuprofen business, potential for margin...
177 Views
Profit from India's Rapidly Growing Biotechnology Industry
Now is a strategic time to focus on the upside potential of biotechnology companies in India, as India’s biotechnology industry is projected to...
5.1k Views